Asterand held two general meetings today – their Annual General Meeting and an extraordinary General Meeting immediately after to approve the sale of part of the business and delisting from the main LSE market. Asterand is a fully listed UK company which operates in the human tissue field. In June 2011 it had a market cap of £15m but now it’s £0.6m, and there appears to be a substantial risk that it will go into administration.
To buy a US company called ...
